NBIX
USDNeurocrine Biosciences Inc. Common Stock
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$141.970
उच्च
$143.870
कम
$140.820
मात्रा
0.26M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
14.3B
उद्योग
Drug Manufacturers - Specialty & Generic
देश
United States
ट्रेडिंग आँकड़े
औसत मात्रा
0.86M
एक्सचेंज
NMS
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
Truist Securities Reiterates Buy on Neurocrine Biosciences, Raises Price Target to $172
Truist Securities analyst Danielle Brill reiterates Neurocrine Biosciences with a Buy and raises the price target from $165 to $172.
Canaccord Genuity Maintains Buy on Neurocrine Biosciences, Raises Price Target to $164
Canaccord Genuity analyst Sumant Kulkarni maintains Neurocrine Biosciences with a Buy and raises the price target from $160 to $164.
Stifel Maintains Buy on Neurocrine Biosciences, Raises Price Target to $183
Stifel analyst Paul Matteis maintains Neurocrine Biosciences with a Buy and raises the price target from $174 to $183.
RBC Capital Maintains Outperform on Neurocrine Biosciences, Raises Price Target to $160
RBC Capital analyst Brian Abrahams maintains Neurocrine Biosciences with a Outperform and raises the price target from $156 to $160.
Piper Sandler Maintains Overweight on Neurocrine Biosciences, Raises Price Target to $179
Piper Sandler analyst David Amsellem maintains Neurocrine Biosciences with a Overweight and raises the price target from $175 to $179.
Needham Maintains Buy on Neurocrine Biosciences, Raises Price Target to $184
Needham analyst Ami Fadia maintains Neurocrine Biosciences with a Buy and raises the price target from $170 to $184.
UBS Maintains Buy on Neurocrine Biosciences, Raises Price Target to $195
UBS analyst Ashwani Verma maintains Neurocrine Biosciences with a Buy and raises the price target from $188 to $195.
संबंधित स्टॉक
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।